Background: Diabetic nephropathy (DN) is one of the main causes of renal failure. Recent research demonstrated that the serial microbes (miRNA) could be used as a marker to detect pathogenic disease; the DN-related miRNAs could not be studied.
Introduction
DIABETES mellitus (DM) is a group of metabolic problems propertied by chronic high blood sugar condition caused by insufficiency of insulin secretion, insulin activity or both [1] . Diabetes mellitus (T2DM) is a dominant type of diabetes and represents at least 90% of all cases of diabetes [2] . The incidence of T2DM has increased exponentially, especially in developed countries [3, 4] . Macro and microvascular complications of diabetes are mainly Correspondence to: Dr. Ahmed M. Hassanain, E-mail: a.hassanain@yahoo.com. due to prolongation of exposure to hyperglycaemia [5] .
Diabetes enhances the individual's risk of developing cardiovascular Disease (CVD) [6, 7] . Diabetes mellitus is also a strong independent prediction of risk stroke and cerebrovascular disease, such as coronary artery disease [8] . Diabetic retinopathy can be the most common microvascular complication of diabetes [9] . Diabetes neuropathy also accompanies diabetes mellitus complications which leads to significant diseases and mortality even in patients with diabetes [10] . Diabetic nephropathy (DN) is a renal complication of diabetes mellitus. The pathogenesis of DN includes the deregulation of various biological functions [11] . A study has estimated about 40% of T2DM patients develop DN [12] .
Among clinical characteristics of DN They include persistent albuminuria and a gradual decrease in glomerular filtration rate (GFR), although low level of albuminuria (30-300mg/day) could be detected in patients with early and reversible DN, evident proteinuria (>300mg/day) represents irreversible level of DN [13] . Analysis of microbiobacteria is an ideal method for detecting DN in early stages, but it has around by problems such as micro albuminuria can develop with advanced medical conditions [14] .
Indeed, a new and more sensitive biomarker for early detection of renal failure with relative minimal invasive sampling and simple experimentation procedure is required [15, 16] . Many studies have suggested the new family of indigenous, small (about 19-22 nucleotides), single stranded noncode RNA molecules known as microRNAs (miR-NAs) as observers development. These molecules 2593 have been shown to play important roles in modulating gene expression [17, 18] . It is estimated that about 60% of human protein-gene coding can be controlled by miRNAs [19] . Several studies have estimated that miRNAs have vital regulators of gene expression, including cancer, hepatitis, and diabetes, [20, 21] . MiRNA29 is involved in pathogenicity DN targets Spry1 in db/db mice or collagen in diabetes mellitus caused by STZ [22, 23] .
Subjects and Methods

Subjects:
The current study was conducted on a total of (120) persons, the study was previously approved by The Ethical Committee of Molecular Biology Dept., Genetic Engineering & Biotechnology Research Institute (GEBRI), university of Sadaat City. Written informed consent was obtained from all patients. The patient's samples (serum) were collected under the approval of National Kidney Institute, Matarya, Cairo, Egypt from May 2018 -July 2018. All patient samples were recruited from the emergency department. Individual were divided into three groups as the following: Group (I): Included (20) healthy volunteers, control group, Group (II): Included (50) consecutive Egyptian T2DM without renal symptoms were constituted as predictive group for renal impairment developing symptoms. Group (III): Included (50) Egyptian T2DM patients with renal insufficiency were suggested of renal impairment.
Blood sampling and serum preparation:
A 7ml Peripheral venous blood was collected and distributed into a 2ml was collected into EDTA tube, stored as a whole blood at 4ºC until used to determine HBA1c level. A 5ml blood was collected into uncoated tube; serum was collected and stored in aliquots at -80ºC until used. Serum samples were divided into two parts. (i) Serum was used to determine (F.B.S, urea & creatinine). (ii) Serum was used to isolate total RNA containing miRNA 29-a.
Urine samples collection & preparation:
Random urine samples were collected, centrifuged; supernatant was collected, and stored at 20ºC until used to determine albumin/creatinine ratio level.
Methods: Biochemical parameters: Estimation of fasting blood sugar level:
Serum glucose was assayed by using Diamond diagnostics Kit (Diamond Diagnostics Company, Cairo, Egypt) according to [24] .
Estimation Glycosylated Hemoglobin (HBA1c) level:
HBA1c was determined by using BIOMED diagnostics Kit (EGY-CHEM Diagnostics Company, Cairo, Egypt) according to [25] .
Estimation of serum urea level:
Serum urea was determined by using Diamond diagnostics Kit (Diamond Diagnostics Company, Cairo, Egypt) according to [26] .
Estimation serum creatinine level:
Serum creatinine level was determined by using Diamond diagnostics Kit (Diamond Diagnostics Company, Cairo, Egypt). Jaffe, colorimetric Kinetic method according to [26] .
Estimation of albumin/creatinine ratio level:
Albumin/Creatinine Ratio level in urine was determined by using BioVision (ACR) kit, (Sunrise TECAN, Austria) according to the manufacturer's instructions.
Real-time reverse transcriptase (RT)-PCR:
In the present study the real-time reverse transcription (RT)-PCR method was used to detect and determine the relative quantitative (RQ) miR29a in subjects serum under study. Total RNA containing small RNA was isolated from 250 µ l of serum using miRNeasy Mini Kit (QIAGEN). Total RNA was converted to cDNA by using the miS-cript®ll RT. Kit (QIAGEN). Real-Time PCR was performed using ViiATM 7 system (Applied Biosystems) by using 2x Quanti Tect SYBR Green PCR Master Mix and RT-PCR reagents Kit to amplify the miRNA29-a cDNA. Briefly, Atypical PCR reaction mix was Prepared as a 25 µ l per well reaction volume as following 2x Quanti Tect SYBR green PCR master mix 12.5 µ l. 10x miScript universal primer 2.5 µ l. 10x miScript primer assay 2.5µ l. RNase-freewater 5 µ l.TemplatecDNA 2.5 µ l. The amplification of the samples were carried out with the following cycling 15min heat start at 95ºC, followed by 40 cycles of denaturation at 94ºC for 15 second, annealing/fluorescence detection at 60ºC for 1min. The internal control gene, noncoding small RNA Hs-SNORD68-11, was used according to the applied biosystems application note. The Relative quantitative (RQ) of miR29-a in the studied subjects were calculated using noncoding small RNA Hs-SNORD68 as an internal control. The point at which the amplification plot crossed the threshold was defined as threshold cycle CT, ACT was determined by subtraction CT that of Hs-SNORD68 (calibrator) from CT of target Group I N=20
Group III N=50
Group II N=50
Mohamed Y. Nasr, et al. 2595 miR29-a, ∆∆CT was calculated by subtraction (∆CT) of control subjects from ( ∆CT) of target miR29-a, finally, Relative quantitative (RQ) of miR29-a=2 ( -∆∆CT ) .
Statistical analysis:
Comparisons among different groups were performed by one way analysis of variance (ANO-VA). It is a parametric statistical analysis that compares between-and within-groups variance to measure differences between two or more groups. All statistical analysis were performed by using statistical software packages namely (SPSS, version 17) (SPSS Inc.Chicago, USA). p-values of less than 0.05 were considered to indicate statistical significance. All these results were expressed as mean ± SD.
Results
Diabetes and kidney functions markers:
The miRNA29-a was assayed and correlated to HBA1 c, fasting blood sugar and renal functions including serum urea & creatinine levels and albumin/creatinine ratio. The present study showed a significantly increased levels of miRNA29a (RQ) (p-value<0.05) in subjects that had a high level of HBA1c & FBS, also an elevated levels of miRNA-29-a were observed in diabetic subjects that had a high levels of urea, creatinine & ACR. We reported that serum miR-29-a was significantly elevated in T2DM patients with aggressive DN, based on ACR, urea and creatinine. Table ( 
Data represented in
Relative quantitative of miRNA29-a
Data represented in Table ( 2) show increased in relative quantitative of miRNA29-a in group III, DN (51.97 ±61.78) and group II, DM (7.06 ± 6.83) when compared with group I, control subjects (0.8±0.2). Also Data represented in Figs. (1A &  1B) show a positive significant correlation between miRNA29-a (RQ) and (ACR & HBA1C), this explains to us the covariant relationship between them. 
Discussion
DN causes significant diseases and even deaths in patients with diabetes. Although the detection of protein in urine samples is considered the best standard to detect one of the first and reversible DN, the sensitivity to diagnosing the exact disease, is dissatisfied [27] . There are many other signs that demonstrate performance in DN analysis or authentication those at risk of development. However, some of these tags cannot be truly special DN and may indicate other types of kidney disease, such as transport and primary glomerulonephritis [28] . The need for highly stable and varied labeling DN and in advance DN individuals are required. The miRNA is well prepared to meet this need. The miRNA is very constant at room temperature [29] .
A recent finding demonstrated that hyperglycemia-induced podocyte dysfunction was ameliorated by miRNA29-a promotion of nephrin acetylation [30] . According to this moment study, a recent study suggesting a series of urinary miRNAs that had not been previously associated kidney disease in patients with T1DM with different levels of albuminurium/DN. Among these miRNAs related to DN, miRNA29 is produced in different ways between patients who developed to DN after a long time in relation to non-patient patients [31] . An increase in the expression of many miRNAs has been observed in diabetes mellitus GK rats model, as increased expression of the myRNA-29 family in muscles, fat and liver, associated with insulin resistance [32] . According to this study is a recent study showed that an elevated level of miR-29a in urine, but not miR-29b and miR-29c, of T2DM patients with microalbuminuria and macroalbuminuria compared to those with normoalbuminuria [33] .
On the contrary, Lv 2013 showed that urinary activities of miR-29 and miR-200 Family decreased in patients with chronic kidney disease, including certain anatomy DN, but the expression miR-29c closely followed the glomerular filtration rate and association not related to the extent of tubulointerstitial fibrosis [34] .
Conclusion
The present data of this study implied that miRNA 29-a could serve as early indicator of DMmediated renal pathogenesis, which can be of importance in the aspect of preventive medicine.
